FdaApplication
ANDA 212727
Identifiers
- fda_app_no: ANDA212727
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2022-03-15 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 4MG BASE | TABLET;ORAL |
| DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 1MG BASE | TABLET;ORAL |
| DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 2MG BASE | TABLET;ORAL |
| DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | EQ 8MG BASE | TABLET;ORAL |
4 products